{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:42:58Z","timestamp":1790678578179,"version":"4.1.0"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10528-018-9841-1","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T05:19:59Z","timestamp":1517375999000},"page":"149-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response"],"prefix":"10.1007","volume":"56","author":[{"given":"Masumeh Maleki","family":"Behzad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Shahrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Jaseb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessika","family":"Bertacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Ketabchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmaldin","family":"Saki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,31]]},"reference":[{"issue":"2","key":"9841_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00441-015-2300-y","volume":"363","author":"A Ahmadzadeh","year":"2016","unstructured":"Ahmadzadeh A, Norozi F, Shahrabi S, Shahjahani M, Saki N (2016) Wnt\/\u03b2-catenin signaling in bone marrow niche. Cell Tissue Res 363(2):321\u2013335","journal-title":"Cell Tissue Res"},{"issue":"2","key":"9841_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.canlet.2008.05.024","volume":"270","author":"M Albajar","year":"2008","unstructured":"Albajar M, Gutierrez P, Richard C, Rosa-Garrido M, G\u00f3mez-Casares MT, Steegmann JL, Le\u00f3n J, Delgado MD (2008) PU. 1 expression is restored upon treatment of chronic myeloid leukemia patients. Cancer Lett 270(2):328\u2013336","journal-title":"Cancer Lett"},{"issue":"5","key":"9841_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1158\/1541-7786.MCR-10-0356","volume":"9","author":"M Albajar","year":"2011","unstructured":"Albajar M, G\u00f3mez-Casares MT, Llorca J, Mauleon I, Vaqu\u00e9 JP, Acosta JC, Berm\u00fadez A, Donato N, Delgado MD, Le\u00f3n J (2011) MYC in chronic myeloid leukemia: induction of aberrant DNA synthesis and association with poor response to imatinib. Mol Cancer Res 9(5):564\u2013576","journal-title":"Mol Cancer Res"},{"issue":"3","key":"9841_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ajh.22272","volume":"87","author":"M Alikian","year":"2012","unstructured":"Alikian M, Gerrard G, Subramanian PG, Mudge K, Foskett P, Khorashad JS, Lim AC, Marin D, Milojkovic D, Reid A (2012) BCR-ABL1 kinase domain mutations: methodology and clinical evaluation. Am J Hematol 87(3):298\u2013304","journal-title":"Am J Hematol"},{"issue":"11","key":"9841_CR5","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.7314\/APJCP.2014.15.11.4555","volume":"15","author":"H Al-Jamal","year":"2014","unstructured":"Al-Jamal H, Jusoh S, Yong AC, Asan JM, Hassan R, Johan MF (2014) Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells. Asian Pac J Cancer Prev 15(11):4555\u20134561","journal-title":"Asian Pac J Cancer Prev"},{"issue":"9","key":"9841_CR6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/gcc.20787","volume":"49","author":"AV Andreeva","year":"2010","unstructured":"Andreeva AV, Kutuzov MA (2010) Cadherin 13 in cancer. Genes Chromosom Cancer 49(9):775\u2013790","journal-title":"Genes Chromosom Cancer"},{"issue":"1","key":"9841_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1179\/1607845413Y.0000000081","volume":"19","author":"S Annamaneni","year":"2014","unstructured":"Annamaneni S, Kagita S, Gorre M, Digumarti RR, Satti V, Battini MR (2014) Methylation status of CEBPA gene promoter in chronic myeloid leukemia. Hematology 19(1):42\u201344","journal-title":"Hematology"},{"issue":"6","key":"9841_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/cas.12655","volume":"106","author":"E Ashihara","year":"2015","unstructured":"Ashihara E, Takada T, Maekawa T (2015) Targeting the canonical Wnt\/\u03b2-catenin pathway in hematological malignancies. Cancer Sci 106(6):665\u2013671","journal-title":"Cancer Sci"},{"issue":"7","key":"9841_CR9","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood.V94.7.2452.419k23_2452_2460","volume":"94","author":"FA Asimakopoulos","year":"1999","unstructured":"Asimakopoulos FA, Shteper PJ, Krichevsky S, Fibach E, Polliack A, Rachmilewitz E, Ben-Neriah Y, Ben-Yehuda D (1999) ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia. Blood 94(7):2452\u20132460","journal-title":"Blood"},{"issue":"4","key":"9841_CR10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1179\/1607845413Y.0000000111","volume":"19","author":"S Azizidoost","year":"2014","unstructured":"Azizidoost S, Babashah S, Rahim F, Shahjahani M, Saki N (2014) Bone marrow neoplastic niche in leukemia. Hematology 19(4):232\u2013238","journal-title":"Hematology"},{"issue":"2","key":"9841_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1179\/1607845414Y.0000000167","volume":"20","author":"S Azizidoost","year":"2015","unstructured":"Azizidoost S, Bavarsad MS, Bavarsad MS, Shahrabi S, Jaseb K, Rahim F, Shahjahani M, Saba F, Ghorbani M, Saki N (2015) The role of notch signaling in bone marrow niche. Hematology 20(2):93\u2013103","journal-title":"Hematology"},{"issue":"6","key":"9841_CR12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.immuni.2005.10.009","volume":"23","author":"Y Baba","year":"2005","unstructured":"Baba Y, Garrett KP, Kincade PW (2005) Constitutively active \u03b2-catenin confers multilineage differentiation potential on lymphoid and myeloid progenitors. Immunity 23(6):599\u2013609","journal-title":"Immunity"},{"issue":"4","key":"9841_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0168-9525(99)01971-X","volume":"16","author":"SB Baylin","year":"2000","unstructured":"Baylin SB, Herman JG (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16(4):168\u2013174","journal-title":"Trends Genet"},{"issue":"5\u20136","key":"9841_CR15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3109\/10428190009059278","volume":"38","author":"Z Beck","year":"2000","unstructured":"Beck Z, Kiss A, T\u00f3th FD, Szab\u00f3 J, B\u00e1csi A, Balogh E, Borb\u00e9ly \u00c1, Telek B, Kov\u00e1cs E, Ol\u00e1h \u00c9 (2000) Alterations of P53 and RB genes and the evolution of the accelerated phase of chronic myeloid leukemia. Leuk lymphoma 38(5\u20136):587\u2013597","journal-title":"Leuk lymphoma"},{"issue":"1","key":"9841_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.7314\/APJCP.2014.15.1.75","volume":"15","author":"K Bodoor","year":"2014","unstructured":"Bodoor K, Haddad Y, Alkhateeb A, Al-Abbadi A, Dowairi M, Magableh A, Bsoul N, Ghabkari A (2014) DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients. Asian Pac J Cancer Prev 15(1):75\u201384","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"9841_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2141.2007.06604.x","volume":"138","author":"J Boultwood","year":"2007","unstructured":"Boultwood J, Wainscoat JS (2007) Gene silencing by DNA methylation in haematological malignancies. Br J Haematol 138(1):3\u201311","journal-title":"Br J Haematol"},{"issue":"5","key":"9841_CR18","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1016\/j.bbagen.2012.11.020","volume":"1830","author":"R Brigelius-Floh\u00e9","year":"2013","unstructured":"Brigelius-Floh\u00e9 R, Maiorino M (2013) Glutathione peroxidases. Biochim Biophys Acta (BBA) 1830(5):3289\u20133303","journal-title":"Biochim Biophys Acta (BBA)"},{"issue":"9","key":"9841_CR19","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/sj.leu.2402214","volume":"15","author":"B Bruecher-Encke","year":"2001","unstructured":"Bruecher-Encke B, Griffin J, Neel B, Lorenz U (2001) Role of the tyrosine phosphatase SHP-1 in K562 cell differentiation. Leukemia 15(9):1424","journal-title":"Leukemia"},{"issue":"1","key":"9841_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1515\/med-2017-0014","volume":"12","author":"H-M Byun","year":"2017","unstructured":"Byun H-M, Eshaghian S, Douer D, Trent J, Garcia-Manero G, Bhatia R, Siegmund K, Yang AS (2017) Impact of chromosomal rearrangement upon DNA methylation patterns in leukemia. Open Med 12(1):76\u201385","journal-title":"Open Med"},{"issue":"1","key":"9841_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3892\/ol.2014.2677","volume":"9","author":"S Celik","year":"2015","unstructured":"Celik S, Akcora D, Ozkan T, Varol N, Aydos S, Sunguroglu A (2015) Methylation analysis of the DAPK1 gene in imatinib-resistant chronic myeloid leukemia patients. Oncol Lett 9(1):399\u2013404","journal-title":"Oncol Lett"},{"issue":"2","key":"9841_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/sj.emboj.7600510","volume":"24","author":"CH Chen","year":"2005","unstructured":"Chen CH, Wang WJ, Kuo JC, Tsai HC, Lin JR, Chang ZF, Chen RH (2005) Bidirectional signals transduced by DAPK\u2013ERK interaction promote the apoptotic effect of DAPK. EMBO J 24(2):294\u2013304","journal-title":"EMBO J"},{"issue":"6","key":"9841_CR23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1089\/gtmb.2012.0530","volume":"17","author":"Q Chen","year":"2013","unstructured":"Chen Q, Lin J, Qian J, Deng Z-Q, Qian W, Yang J, Li Y, Chen X-X, Ma Y-J, Ma J-C (2013) The methylation status of the DDX43 promoter in Chinese patients with chronic myeloid leukemia. Genet Test Mol Biomark 17(6):508\u2013511","journal-title":"Genet Test Mol Biomark"},{"issue":"5","key":"9841_CR24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2141.2004.05246.x","volume":"127","author":"C Chim","year":"2004","unstructured":"Chim C, Kwong Y (2004) How frequent is SOCS1 methylation in acute myeloid leukaemia? Br J Haematol 127(5):609\u2013611","journal-title":"Br J Haematol"},{"issue":"9","key":"9841_CR25","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1136\/jcp.2005.035089","volume":"59","author":"C Chim","year":"2006","unstructured":"Chim C, Fung T, Wong K, Lau J, Law M, Liang R (2006) Methylation of INK4 and CIP\/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients. J Clin Pathol 59(9):921\u2013926","journal-title":"J Clin Pathol"},{"issue":"9","key":"9841_CR26","first-page":"55","volume":"4","author":"Y-M Chin","year":"2014","unstructured":"Chin Y-M, Yacob AM, Ramachandran S, Zakaria Z (2014) DNA methylation of SLC5A8, a tumor suppressor gene in chronic myeloid leukemia. Int J Health Sci Res (IJHSR) 4(9):55\u201360","journal-title":"Int J Health Sci Res (IJHSR)"},{"issue":"10","key":"9841_CR27","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MW Deininger","year":"2000","unstructured":"Deininger MW, Goldman JM, Melo JV (2000) The molecular biology of chronic myeloid leukemia. Blood 96(10):3343\u20133356","journal-title":"Blood"},{"issue":"21","key":"9841_CR28","doi-asserted-by":"publisher","first-page":"8896","DOI":"10.1158\/0008-5472.CAN-10-0258","volume":"70","author":"M Della Peruta","year":"2010","unstructured":"Della Peruta M, Martinelli G, Moratti E, Pintani D, Vezzalini M, Mafficini A, Grafone T, Iacobucci I, Soverini S, Murineddu M (2010) Protein tyrosine phosphatase receptor type \u03b3 is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia. Can Res 70(21):8896\u20138906","journal-title":"Can Res"},{"issue":"7","key":"9841_CR29","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1182\/blood.V97.7.2084","volume":"97","author":"E Deutsch","year":"2001","unstructured":"Deutsch E, Dugray A, AbdulKarim B, Marangoni E, Maggiorella L, Vaganay S, M\u2019Kacher R, Rasy SD, Eschwege F, Vainchenker W (2001) BCR-ABL down-regulates the DNA repair protein DNA-PKcs. Blood 97(7):2084\u20132090","journal-title":"Blood"},{"issue":"11","key":"9841_CR30","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1182\/blood-2002-10-3011","volume":"101","author":"E Deutsch","year":"2003","unstructured":"Deutsch E, Jarrousse S, Buet D, Dugray A, Bonnet M-L, Vozenin-Brotons M-C, Guilhot F, Turhan AG, Feunteun J, Bourhis J (2003) Down-regulation of BRCA1 in BCR-ABL\u2013expressing hematopoietic cells. Blood 101(11):4583\u20134588","journal-title":"Blood"},{"issue":"3","key":"9841_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1182\/blood-2015-01-621664","volume":"126","author":"H Dombret","year":"2015","unstructured":"Dombret H, Seymour JF, Butrym A, Wierzbowska A, Selleslag D, Jang JH, Kumar R, Cavenagh J, Schuh AC, Candoni A (2015) International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with\u00a0>\u00a030% blasts. Blood 126(3):291\u2013299","journal-title":"Blood"},{"key":"9841_CR32","doi-asserted-by":"crossref","unstructured":"Elias MH, Baba AA, Husin A, Sulong S, Hassan V, Sim GA, Abdul Wahid SF, Ankathil R (2012) HOXA4 gene promoter hypermethylation as an epigenetic mechanism mediating resistance to imatinib mesylate in chronic myeloid leukemia patients. BioMed Res Int","DOI":"10.1155\/2013\/129715"},{"issue":"6","key":"9841_CR33","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2005.07.003","volume":"122","author":"MT Epping","year":"2005","unstructured":"Epping MT, Wang L, Edel MJ, Carl\u00e9e L, Hernandez M, Bernards R (2005) The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell 122(6):835\u2013847","journal-title":"Cell"},{"issue":"7","key":"9841_CR34","first-page":"2816","volume":"61","author":"M Esteller","year":"2001","unstructured":"Esteller M, Cordon-Cardo C, Corn PG, Meltzer SJ, Pohar KS, Watkins DN, Capella G, Peinado MA, Matias-Guiu X, Prat J (2001) p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2. Can Res 61(7):2816\u20132821","journal-title":"Can Res"},{"issue":"1","key":"9841_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/scd.2011.0259","volume":"21","author":"M Fournier","year":"2011","unstructured":"Fournier M, Lebert-Ghali C-\u00c9, Krosl G, Bijl JJ (2011) HOXA4 induces expansion of hematopoietic stem cells in vitro and confers enhancement of pro-B-cells in vivo. Stem Cells Dev 21(1):133\u2013142","journal-title":"Stem Cells Dev"},{"issue":"1","key":"9841_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0092-8674(02)00961-3","volume":"111","author":"L Fu","year":"2002","unstructured":"Fu L, Pelicano H, Liu J, Huang P, Lee CC (2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111(1):41\u201350","journal-title":"Cell"},{"issue":"12","key":"9841_CR37","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.1158\/0008-5472.CAN-06-0157","volume":"66","author":"J Furuta","year":"2006","unstructured":"Furuta J, Nobeyama Y, Umebayashi Y, Otsuka F, Kikuchi K, Ushijima T (2006) Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas. Can Res 66(12):6080\u20136086","journal-title":"Can Res"},{"issue":"7","key":"9841_CR38","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1182\/blood-2002-06-1735","volume":"101","author":"O Galm","year":"2003","unstructured":"Galm O, Yoshikawa H, Esteller M, Osieka R, Herman JG (2003) SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood 101(7):2784\u20132788","journal-title":"Blood"},{"issue":"3","key":"9841_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/sj.leu.2403267","volume":"18","author":"Y Gao","year":"2004","unstructured":"Gao Y, Xiong D, Yang M, Liu H, Peng H, Shao X, Xu Y, Xu C, Fan D, Qin L (2004) Efficient inhibition of multidrug-resistant human tumors with a recombinant bispecific anti-P-glycoprotein\u00a0\u00d7\u00a0anti-CD3 diabody. Leukemia 18(3):513\u2013520","journal-title":"Leukemia"},{"issue":"7","key":"9841_CR40","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3324\/haematol.2012.074831","volume":"98","author":"SD Gore","year":"2013","unstructured":"Gore SD, Fenaux P, Santini V, Bennett JM, Silverman LR, Seymour JF, Hellstr\u00f6m-Lindberg E, Swern AS, Beach CL, List AF (2013) A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial. Haematologica 98(7):1067\u20131072","journal-title":"Haematologica"},{"issue":"3","key":"9841_CR41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1189\/jlb.70.3.348","volume":"70","author":"CJ Greenhalgh","year":"2001","unstructured":"Greenhalgh CJ, Hilton DJ (2001) Negative regulation of cytokine signaling. J Leukoc Biol 70(3):348\u2013356","journal-title":"J Leukoc Biol"},{"issue":"2","key":"9841_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.trecan.2015.12.006","volume":"2","author":"M Guillamot","year":"2016","unstructured":"Guillamot M, Cimmino L, Aifantis I (2016) The impact of DNA methylation in hematopoietic malignancies. Trends Cancer 2(2):70\u201383","journal-title":"Trends Cancer"},{"issue":"3\u20134","key":"9841_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/10428199709051771","volume":"26","author":"B-A Guinn","year":"1997","unstructured":"Guinn B-A, Mills KI (1997) p53 mutations, methylation and genomic instability in the progression of chronic myeloid leukaemia. Leuk Lymphoma 26(3\u20134):211\u2013226","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"9841_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0145-2126(99)00158-7","volume":"24","author":"S-X Guo","year":"2000","unstructured":"Guo S-X, Taki T, Ohnishi H, Piao H-Y, Tabuchi K, Bessho F, Hanada R, Yanagisawa M, Hayashi Y (2000) Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia. Leuk Res 24(1):39\u201346","journal-title":"Leuk Res"},{"issue":"6","key":"9841_CR45","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","volume":"119","author":"A Hamilton","year":"2012","unstructured":"Hamilton A, Helgason GV, Schemionek M, Zhang B, Myssina S, Allan EK, Nicolini FE, M\u00fcller-Tidow C, Bhatia R, Brunton VG (2012) Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival. Blood 119(6):1501\u20131510","journal-title":"Blood"},{"issue":"5","key":"9841_CR46","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.athoracsur.2014.12.058","volume":"99","author":"H Harada","year":"2015","unstructured":"Harada H, Miyamoto K, Yamashita Y, Taniyama K, Ohdan H, Okada M (2015) Methylated DLX4 predicts response to pathologic stage I non-small cell lung cancer resection. Ann Thorac Surg 99(5):1746\u20131754","journal-title":"Ann Thorac Surg"},{"issue":"Suppl 1","key":"9841_CR47","first-page":"9","volume":"19","author":"N Heidari","year":"2017","unstructured":"Heidari N, Abroun S, Bertacchini J, Vosoughi T, Rahim F, Saki N (2017) Significance of inactivated genes in leukemia: pathogenesis and prognosis. Cell Journal (Yakhteh) 19(Suppl 1):9","journal-title":"Cell Journal (Yakhteh)"},{"issue":"9","key":"9841_CR48","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1038\/leu.2016.143","volume":"30","author":"G Heller","year":"2016","unstructured":"Heller G, Topakian T, Altenberger C, Cerny-Reiterer S, Herndlhofer S, Ziegler B, Datlinger P, Byrgazov K, Bock C, Mannhalter C (2016) Next-generation sequencing identifies major DNA methylation changes during progression of Ph\u00a0+\u00a0chronic myeloid leukemia. Leukemia 30(9):1861\u20131868","journal-title":"Leukemia"},{"issue":"6","key":"9841_CR49","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/leu.2009.38","volume":"23","author":"A Hochhaus","year":"2009","unstructured":"Hochhaus A, O\u2019brien S, Guilhot F, Druker B, Branford S, Foroni L, Goldman J, M\u00fcller M, Radich J, Rudoltz M (2009) Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia 23(6):1054\u20131061","journal-title":"Leukemia"},{"issue":"4","key":"9841_CR50","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.3892\/ol.2016.4317","volume":"11","author":"Q Hong","year":"2016","unstructured":"Hong Q, Chen X, Ye H, Zhou A, Gao Y, Jiang D, Wu X, Tian B, Chen Y, Wang M (2016) Association between the methylation status of the MGMT promoter in bone marrow specimens and chemotherapy outcomes of patients with acute myeloid leukemia. Oncol Lett 11(4):2851\u20132856","journal-title":"Oncol Lett"},{"key":"9841_CR51","first-page":"141","volume":"4","author":"A Imtiyaz","year":"2013","unstructured":"Imtiyaz A, Rashid M, Sameer G, Jamsheed J, Mariyam Z (2013) Inactivation of P16 (INK4a) gene by promoter hypermethylation is associated with disease progression in chronic myelogenous leukaemia. J Carcinog Mutagen 4:141","journal-title":"J Carcinog Mutagen"},{"issue":"12","key":"9841_CR52","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.18632\/oncotarget.1938","volume":"5","author":"HS Isaksson","year":"2014","unstructured":"Isaksson HS, Sorbe B, Nilsson TK (2014) Whole genome expression profiling of blood cells in ovarian cancer patients-prognostic impact of the CYP1B1, MTSS1, NCALD, and NOP14 genes. Oncotarget 5(12):4040","journal-title":"Oncotarget"},{"issue":"17","key":"9841_CR53","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1200\/JCO.2005.11.981","volume":"23","author":"J-PJ Issa","year":"2005","unstructured":"Issa J-PJ, Gharibyan V, Cortes J, Jelinek J, Morris G, Verstovsek S, Talpaz M, Garcia-Manero G, Kantarjian HM (2005) Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate. J Clin Oncol 23(17):3948\u20133956","journal-title":"J Clin Oncol"},{"issue":"8","key":"9841_CR55","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/sj.cgt.7700828","volume":"12","author":"ST Jacob","year":"2005","unstructured":"Jacob ST, Motiwala T (2005) Epigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy. Cancer Gene Ther 12(8):665\u2013672","journal-title":"Cancer Gene Ther"},{"issue":"6","key":"9841_CR56","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3324\/haematol.2009.015693","volume":"95","author":"JJ Janssen","year":"2010","unstructured":"Janssen JJ, Denkers F, Valk P, Cornelissen JJ, Schuurhuis G-J, Ossenkoppele GJ (2010) Methylation patterns in CD34 positive chronic myeloid leukemia blast crisis cells. Haematologica 95(6):1036\u20131037","journal-title":"Haematologica"},{"issue":"7","key":"9841_CR57","doi-asserted-by":"publisher","first-page":"e22110","DOI":"10.1371\/journal.pone.0022110","volume":"6","author":"J Jelinek","year":"2011","unstructured":"Jelinek J, Gharibyan V, Estecio MR, Kondo K, He R, Chung W, Lu Y, Zhang N, Liang S, Kantarjian HM (2011) Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia. PLoS ONE 6(7):e22110","journal-title":"PLoS ONE"},{"issue":"5","key":"9841_CR58","doi-asserted-by":"publisher","first-page":"e96822","DOI":"10.1371\/journal.pone.0096822","volume":"9","author":"D Jiang","year":"2014","unstructured":"Jiang D, Hong Q, Shen Y, Xu Y, Zhu H, Li Y, Xu C, Ouyang G, Duan S (2014) The diagnostic value of DNA methylation in leukemia: a systematic review and meta-analysis. PLoS ONE 9(5):e96822","journal-title":"PLoS ONE"},{"issue":"3","key":"9841_CR59","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/cncr.11543","volume":"98","author":"HM Kantarjian","year":"2003","unstructured":"Kantarjian HM, O\u2019Brien S, Cortes J, Giles FJ, Faderl S, Issa JP, Garcia-Manero G, Rios MB, Shan J, Andreeff M (2003) Results of decitabine (5-aza-2\u2032 deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia. Cancer 98(3):522\u2013528","journal-title":"Cancer"},{"issue":"4","key":"9841_CR60","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1182\/blood-2010-03-277152","volume":"117","author":"HM Kantarjian","year":"2011","unstructured":"Kantarjian HM, Giles FJ, Bhalla KN, Pinilla-Ibarz J, Larson RA, Gattermann N, Ottmann OG, Hochhaus A, Radich JP, Saglio G (2011) Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results. Blood 117(4):1141\u20131145","journal-title":"Blood"},{"issue":"1","key":"9841_CR61","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3892\/ol.2010.208","volume":"2","author":"Y Koh","year":"2011","unstructured":"Koh Y, Kim D-Y, Park S-H, Byun H-M, Kim I, Yoon S-S, Kim BK, Park E, Park S (2011) Increased BCR promoter DNA methylation status strongly correlates with favorable response to imatinib in chronic myeloid leukemia patients. Oncol Lett 2(1):181\u2013187","journal-title":"Oncol Lett"},{"key":"9841_CR62","doi-asserted-by":"crossref","unstructured":"Koschmieder S, Vetrie D (2017) Epigenetic dysregulation in chronic myeloid leukaemia: a myriad of mechanisms and therapeutic options. Seminars in cancer biology. Elsevier","DOI":"10.1016\/j.semcancer.2017.07.006"},{"issue":"13","key":"9841_CR63","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/ajmg.a.31252","volume":"140","author":"P Kraus","year":"2006","unstructured":"Kraus P, Lufkin T (2006) Dlx homeobox gene control of mammalian limb and craniofacial development. Am J Med Genet Part A 140(13):1366\u20131374","journal-title":"Am J Med Genet Part A"},{"issue":"5","key":"9841_CR64","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1007\/s12032-012-0289-6","volume":"29","author":"NK Kurtovi\u0107","year":"2012","unstructured":"Kurtovi\u0107 NK, Krajnovi\u0107 M, Bogdanovi\u0107 A, Suvajd\u017ei\u0107 N, Jovanovi\u0107 J, Dimitrijevi\u0107 B, \u010colovi\u0107 M, Krtolica K (2012) Concomitant aberrant methylation of p15 and MGMT genes in acute myeloid leukemia: association with a particular immunophenotype of blast cells. Med Oncol 29(5):3547\u20133556","journal-title":"Med Oncol"},{"issue":"1","key":"9841_CR65","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1182\/blood-2003-04-1074","volume":"103","author":"P Ros\u00e9e La","year":"2004","unstructured":"La Ros\u00e9e P, Johnson K, Corbin AS, Stoffregen EP, Moseson EM, Willis S, Mauro MM, Melo JV, Deininger MW, Druker BJ (2004) In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl\u2013positive cell lines. Blood 103(1):208\u2013215","journal-title":"Blood"},{"issue":"11","key":"9841_CR66","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1073\/pnas.88.11.5036","volume":"88","author":"S LaForgia","year":"1991","unstructured":"LaForgia S, Morse B, Levy J, Barnea G, Cannizzaro L, Li F, Nowell P, Boghosian-Sell L, Glick J, Weston A (1991) Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21. Proc Natl Acad Sci 88(11):5036\u20135040","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"9841_CR67","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1128\/MCB.18.5.2965","volume":"18","author":"KR LaMontagne","year":"1998","unstructured":"LaMontagne KR, Flint AJ, Franza BR, Pendergast AM, Tonks NK (1998) Protein tyrosine phosphatase 1B antagonizes signalling by oncoprotein tyrosine kinase p210 bcr-abl in vivo. Mol Cell Biol 18(5):2965\u20132975","journal-title":"Mol Cell Biol"},{"issue":"19","key":"9841_CR68","first-page":"5548","volume":"60","author":"F Page Le","year":"2000","unstructured":"Le Page F, Randrianarison V, Marot D, Cabannes J, Perricaudet M, Feunteun J, Sarasin A (2000) BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Can Res 60(19):5548\u20135552","journal-title":"Can Res"},{"issue":"3","key":"9841_CR69","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/bjh.12023","volume":"159","author":"E Leo","year":"2012","unstructured":"Leo E, Mancini M, Aluigi M, Castagnetti F, Martinelli G, Barbieri E, Santucci MA (2012) DNA hypermethylation promotes the low expression of pro-apoptotic BCL2L11 associated with BCR-ABL1 fusion gene of chronic myeloid leukaemia. Br J Haematol 159(3):373\u2013376","journal-title":"Br J Haematol"},{"issue":"12","key":"9841_CR70","doi-asserted-by":"publisher","first-page":"e81425","DOI":"10.1371\/journal.pone.0081425","volume":"8","author":"E Leo","year":"2013","unstructured":"Leo E, Mancini M, Aluigi M, Luatti S, Castagnetti F, Testoni N, Soverini S, Santucci MA, Martinelli G (2013) BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia. PLoS ONE 8(12):e81425","journal-title":"PLoS ONE"},{"issue":"7","key":"9841_CR71","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/annonc\/mdp569","volume":"21","author":"R Li","year":"2009","unstructured":"Li R, Zhang G, Chen Y, Zhu J, Lu Q, Gong F, Kuang W (2009) Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance. Ann Oncol 21(7):1506\u20131514","journal-title":"Ann Oncol"},{"issue":"5","key":"9841_CR72","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.3892\/or.2014.3098","volume":"31","author":"Y Li","year":"2014","unstructured":"Li Y, Yang L, Pan Y, Yang J, Shang Y, Luo J (2014) Methylation and decreased expression of SHP-1 are related to disease progression in chronic myelogenous leukemia. Oncol Rep 31(5):2438\u20132446","journal-title":"Oncol Rep"},{"key":"9841_CR73","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.leukres.2017.03.014","volume":"58","author":"Y Li","year":"2017","unstructured":"Li Y, Liu X, Guo X, Liu X, Luo J (2017) DNA methyltransferase 1 mediated aberrant methylation and silencing of SHP-1 gene in chronic myelogenous leukemia cells. Leuk Res 58:9\u201313","journal-title":"Leuk Res"},{"issue":"4","key":"9841_CR74","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1046\/j.1365-2141.2003.04660.x","volume":"123","author":"TC Liu","year":"2003","unstructured":"Liu TC, Lin SF, Chang JG, Yang MY, Hung SY, Chang CS (2003) Epigenetic alteration of the SOCS1 gene in chronic myeloid leukaemia. Br J Haematol 123(4):654\u2013661","journal-title":"Br J Haematol"},{"issue":"1","key":"9841_CR75","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1600-065X.2008.00760.x","volume":"228","author":"U Lorenz","year":"2009","unstructured":"Lorenz U (2009) SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol Rev 228(1):342\u2013359","journal-title":"Immunol Rev"},{"issue":"7","key":"9841_CR76","doi-asserted-by":"publisher","first-page":"e0131074","DOI":"10.1371\/journal.pone.0131074","volume":"10","author":"M Mancini","year":"2015","unstructured":"Mancini M, Leo E, Takemaru K-I, Campi V, Castagnetti F, Soverini S, De Benedittis C, Rosti G, Cavo M, Santucci MA (2015) 14-3-3 binding and sumoylation concur to the down-modulation of \u03b2-catenin antagonist chibby 1 in chronic myeloid leukemia. PLoS ONE 10(7):e0131074","journal-title":"PLoS ONE"},{"issue":"6","key":"9841_CR77","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrc2147","volume":"7","author":"JV Melo","year":"2007","unstructured":"Melo JV, Barnes DJ (2007) Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 7(6):441\u2013453","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"9841_CR78","first-page":"250","volume":"24","author":"Z Meng","year":"2016","unstructured":"Meng Z, Li Y-H (2016) One of the mechanisms in blastic transformation of chronic myeloid leukemia: epigenetics abnormality-review. Zhongguo shi yan xue ye xue za zhi 24(1):250\u2013253","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"issue":"12","key":"9841_CR79","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nrc2231","volume":"8","author":"N Meyer","year":"2008","unstructured":"Meyer N, Penn LZ (2008) Reflecting on 25\u00a0years with MYC. Nat Rev Cancer 8(12):976\u2013990","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"9841_CR80","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1182\/blood.V97.5.1172","volume":"97","author":"S-I Mizuno","year":"2001","unstructured":"Mizuno S-I, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H (2001) Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 97(5):1172\u20131179","journal-title":"Blood"},{"key":"9841_CR81","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0079-6603(06)81008-1","volume":"81","author":"T Motiwala","year":"2006","unstructured":"Motiwala T, Jacob ST (2006) Role of protein tyrosine phosphatases in cancer. Prog Nucl Acid Res Mol Biol 81:297\u2013329","journal-title":"Prog Nucl Acid Res Mol Biol"},{"issue":"38","key":"9841_CR82","doi-asserted-by":"publisher","first-page":"13844","DOI":"10.1073\/pnas.0405451101","volume":"101","author":"T Motiwala","year":"2004","unstructured":"Motiwala T, Kutay H, Ghoshal K, Bai S, Seimiya H, Tsuruo T, Suster S, Morrison C, Jacob ST (2004) Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer. Proc Natl Acad Sci USA 101(38):13844\u201313849","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9841_CR83","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1074\/jbc.M802840200","volume":"284","author":"T Motiwala","year":"2009","unstructured":"Motiwala T, Majumder S, Ghoshal K, Kutay H, Datta J, Roy S, Lucas DM, Jacob ST (2009) PTPROt inactivates the oncogenic fusion protein BCR\/ABL and suppresses transformation of K562 cells. J Biol Chem 284(1):455\u2013464","journal-title":"J Biol Chem"},{"issue":"1","key":"9841_CR84","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.canlet.2011.08.002","volume":"312","author":"R Nagao","year":"2011","unstructured":"Nagao R, Ashihara E, Kimura S, Strovel JW, Yao H, Takeuchi M, Tanaka R, Hayashi Y, Hirai H, Padia J (2011) Growth inhibition of imatinib-resistant CML cells with the T315I mutation and hypoxia-adaptation by AV65\u2013a novel Wnt\/\u03b2-catenin signaling inhibitor. Cancer Lett 312(1):91\u2013100","journal-title":"Cancer Lett"},{"issue":"16","key":"9841_CR85","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/S0959-8049(03)00552-5","volume":"39","author":"E Nagy","year":"2003","unstructured":"Nagy E, Beck Z, Kiss A, Csoma E, Telek B, Konya J, Olah E, Rak K, Toth F (2003) Frequent methylation of p16 INK4A and p14 ARF genes implicated in the evolution of chronic myeloid leukaemia from its chronic to accelerated phase. Eur J Cancer 39(16):2298\u20132305","journal-title":"Eur J Cancer"},{"issue":"9","key":"9841_CR86","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1182\/blood.V95.9.2990.009k08_2990_2992","volume":"95","author":"TT Nguyen","year":"2000","unstructured":"Nguyen TT, Mohrbacher AF, Tsai YC, Groffen J, Heisterkamp N, Nichols PW, Mimi CY, L\u00fcbbert M, Jones PA (2000) Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implications. Blood 95(9):2990\u20132992","journal-title":"Blood"},{"issue":"3","key":"9841_CR87","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/ng.3488","volume":"48","author":"CC Oakes","year":"2016","unstructured":"Oakes CC, Seifert M, Assenov Y, Gu L, Przekopowitz M, Ruppert AS, Wang Q, Imbusch CD, Serva A, Koser SD (2016) DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nat Genet 48(3):253\u2013264","journal-title":"Nat Genet"},{"issue":"2","key":"9841_CR88","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/emboj\/17.2.384","volume":"17","author":"L O\u2019Connor","year":"1998","unstructured":"O\u2019Connor L, Strasser A, O\u2019Reilly LA, Hausmann G, Adams JM, Cory S, Huang DC (1998) Bim: a novel member of the Bcl-2 family that promotes apoptosis. The EMBO journal 17(2):384\u2013395","journal-title":"The EMBO journal"},{"issue":"22","key":"9841_CR89","first-page":"6390","volume":"62","author":"T Oka","year":"2002","unstructured":"Oka T, Ouchida M, Koyama M, Ogama Y, Takada S, Nakatani Y, Tanaka T, Yoshino T, Hayashi K, Ohara N (2002) Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias\/lymphomas. Can Res 62(22):6390\u20136394","journal-title":"Can Res"},{"issue":"5","key":"9841_CR90","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/cncr.22470","volume":"109","author":"Y Oki","year":"2007","unstructured":"Oki Y, Kantarjian HM, Gharibyan V, Jones D, O\u2019Brien S, Verstovsek S, Cortes J, Morris GM, Garcia-Manero G, Issa JP (2007) Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia. Cancer 109(5):899\u2013906","journal-title":"Cancer"},{"issue":"3","key":"9841_CR91","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.lungcan.2012.11.019","volume":"79","author":"JY Park","year":"2013","unstructured":"Park JY, Kim D, Yang M, Park HY, Lee SH, Rincon M, Kreahling J, Plass C, Smiraglia DJ, Tockman MS (2013) Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer. Lung Cancer 79(3):198\u2013204","journal-title":"Lung Cancer"},{"issue":"3","key":"9841_CR92","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.leukres.2006.06.022","volume":"31","author":"S Paydas","year":"2007","unstructured":"Paydas S, Tanriverdi K, Yavuz S, Seydaoglu G (2007) PRAME mRNA levels in cases with chronic leukemia: clinical importance and review of the literature. Leuk Res 31(3):365\u2013369","journal-title":"Leuk Res"},{"issue":"8","key":"9841_CR93","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.leukres.2008.11.013","volume":"33","author":"M Pehlivan","year":"2009","unstructured":"Pehlivan M, Sercan Z, Sercan HO (2009) sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia. Leuk Res 33(8):1062\u20131067","journal-title":"Leuk Res"},{"issue":"3","key":"9841_CR94","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1590\/S1516-84842009005000050","volume":"31","author":"MCR Pena","year":"2009","unstructured":"Pena MCR, Pardini MI, Colturato VA, Pinheiro NA (2009) Methylation status of the SOCS 1 and JUNB genes in chronic myeloid leukemia patients. Revista Brasileira de Hematologia e Hemoterapia 31(3):147\u2013152","journal-title":"Revista Brasileira de Hematologia e Hemoterapia"},{"issue":"1","key":"9841_CR95","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ng791","volume":"30","author":"D Perrotti","year":"2002","unstructured":"Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, Campbell K, Iervolino A, Condorelli F, Gambacorti-Passerini C, Caligiuri MA (2002) BCR-ABL suppresses C\/EBP\u03b1 expression through inhibitory action of hnRNP E2. Nat Genet 30(1):48\u201358","journal-title":"Nat Genet"},{"issue":"7","key":"9841_CR96","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1172\/JCI41246","volume":"120","author":"D Perrotti","year":"2010","unstructured":"Perrotti D, Jamieson C, Goldman J, Skorski T (2010) Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Investig 120(7):2254","journal-title":"J Clin Investig"},{"issue":"2","key":"9841_CR97","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1600-0609.2008.01178.x","volume":"82","author":"J Qian","year":"2009","unstructured":"Qian J, Wang Yl, Lin J, Yao Dm, Xu Wr, Wu Cy (2009) Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia. Eur J Haematol 82(2):119\u2013123","journal-title":"Eur J Haematol"},{"issue":"7","key":"9841_CR98","doi-asserted-by":"publisher","first-page":"973","DOI":"10.4065\/81.7.973","volume":"81","author":"A Quint\u00e1s-Cardama","year":"2006","unstructured":"Quint\u00e1s-Cardama A, Cortes JE (2006) Chronic myeloid leukemia: diagnosis and treatment. Mayo Clin Proc 81(7):973\u2013988","journal-title":"Mayo Clin Proc"},{"issue":"15","key":"9841_CR99","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1158\/0008-5472.CAN-03-3656","volume":"64","author":"P Ramaraj","year":"2004","unstructured":"Ramaraj P, Singh H, Niu N, Chu S, Holtz M, Yee JK, Bhatia R (2004) Effect of mutational inactivation of tyrosine kinase activity on BCR\/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors. Can Res 64(15):5322\u20135331","journal-title":"Can Res"},{"issue":"1","key":"9841_CR100","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12943-015-0458-2","volume":"14","author":"E Raveh","year":"2015","unstructured":"Raveh E, Matouk IJ, Gilon M, Hochberg A (2015) The H19 Long non-coding RNA in cancer initiation, progression and metastasis\u2013a proposed unifying theory. Mol Cancer 14(1):184","journal-title":"Mol Cancer"},{"issue":"8","key":"9841_CR101","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1200\/JCO.2003.08.166","volume":"21","author":"J Roman-Gomez","year":"2003","unstructured":"Roman-Gomez J, Castillejo JA, Jimenez A, Cervantes F, Boque C, Hermosin L, Leon A, Gra\u00f1ena A, Colomer D, Heiniger A (2003) Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa. J Clin Oncol 21(8):1472\u20131479","journal-title":"J Clin Oncol"},{"issue":"2","key":"9841_CR102","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3324\/haematol.10782","volume":"92","author":"J Roman-Gomez","year":"2007","unstructured":"Roman-Gomez J, Jimenez-Velasco A, Agirre X, Castillejo JA, Navarro G, San Jose-Eneriz E, Garate L, Cordeu L, Cervantes F, Prosper F (2007a) Epigenetic regulation of human cancer\/testis antigen gene, HAGE, in chronic myeloid leukemia. Haematologica 92(2):153\u2013162","journal-title":"Haematologica"},{"issue":"11","key":"9841_CR103","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.leukres.2007.02.016","volume":"31","author":"J Roman-Gomez","year":"2007","unstructured":"Roman-Gomez J, Jimenez-Velasco A, Agirre X, Castillejo JA, Navarro G, San Jose-Eneriz E, Garate L, Cordeu L, Cervantes F, Prosper F (2007b) Epigenetic regulation of PRAME gene in chronic myeloid leukemia. Leuk Res 31(11):1521\u20131528","journal-title":"Leuk Res"},{"issue":"6","key":"9841_CR104","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/ng1361","volume":"36","author":"F Rosenbauer","year":"2004","unstructured":"Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, Okuno Y, Akashi K, Fiering S, Tenen DG (2004) Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU. 1. Nat Genet 36(6):624\u2013630","journal-title":"Nat Genet"},{"issue":"2","key":"9841_CR105","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.exphem.2004.08.015","volume":"33","author":"AG Rosmarin","year":"2005","unstructured":"Rosmarin AG, Yang Z, Resendes KK (2005) Transcriptional regulation in myelopoiesis: hematopoietic fate choice, myeloid differentiation, and leukemogenesis. Exp Hematol 33(2):131\u2013143","journal-title":"Exp Hematol"},{"issue":"6","key":"9841_CR106","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/dc.23256","volume":"43","author":"J Sakane","year":"2015","unstructured":"Sakane J, Taniyama K, Miyamoto K, Saito A, Kuraoka K, Nishimura T, Sentani K, Oue N, Yasui W (2015) Aberrant DNA methylation of DLX4 and SIM1 is a predictive marker for disease progression of uterine cervical low-grade squamous intraepithelial lesion. Diagn Cytopathol 43(6):462\u2013470","journal-title":"Diagn Cytopathol"},{"issue":"3","key":"9841_CR107","first-page":"131","volume":"13","author":"N Saki","year":"2011","unstructured":"Saki N, Abroun S, Hagh MF, Asgharei F (2011) Neoplastic bone marrow niche: hematopoietic and mesenchymal stem cells. Cell J (Yakhteh) 13(3):131","journal-title":"Cell J (Yakhteh)"},{"issue":"3","key":"9841_CR108","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/leu.2010.287","volume":"25","author":"A Samanta","year":"2011","unstructured":"Samanta A, Perazzona B, Chakraborty S, Sun X, Modi H, Bhatia R, Priebe W, Arlinghaus R (2011) Janus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia. Leukemia 25(3):463\u2013472","journal-title":"Leukemia"},{"issue":"10","key":"9841_CR109","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.ejca.2009.04.005","volume":"45","author":"E San Jos\u00e9-Eneriz","year":"2009","unstructured":"San Jos\u00e9-Eneriz E, Agirre X, Jim\u00e9nez-Velasco A, Cordeu L, Mart\u00edn V, Arqueros V, G\u00e1rate L, Fresquet V, Cervantes F, Mart\u00ednez-Climent JA (2009) Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia. Eur J Cancer 45(10):1877\u20131889","journal-title":"Eur J Cancer"},{"issue":"5","key":"9841_CR110","doi-asserted-by":"publisher","first-page":"e0125783","DOI":"10.1371\/journal.pone.0125783","volume":"10","author":"M Schemionek","year":"2015","unstructured":"Schemionek M, Masouleh BK, Klaile Y, Krug U, Hebestreit K, Schubert C, Dugas M, B\u00fcchner T, W\u00f6rmann B, Hiddemann W (2015) Identification of the adapter molecule MTSS1 as a potential oncogene-specific tumor suppressor in acute myeloid leukemia. PLoS ONE 10(5):e0125783","journal-title":"PLoS ONE"},{"issue":"4","key":"9841_CR111","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/leu.2015.329","volume":"30","author":"M Schemionek","year":"2016","unstructured":"Schemionek M, Herrmann O, Reher MM, Chatain N, Schubert C, Costa I, H\u00e4nzelmann S, Gusmao E, Kintsler S, Braunschweig T (2016) Mtss1 is a critical epigenetically regulated tumor suppressor in CML. Leukemia 30(4):823\u2013832","journal-title":"Leukemia"},{"issue":"3","key":"9841_CR112","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.bcp.2010.10.013","volume":"81","author":"M Schnekenburger","year":"2011","unstructured":"Schnekenburger M, Grandjenette C, Ghelfi J, Karius T, Foliguet B, Dicato M, Diederich M (2011) Sustained exposure to the DNA demethylating agent, 2\u2032-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagy. Biochem Pharmacol 81(3):364\u2013378","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"9841_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/leu.2013.242","volume":"28","author":"T Schoofs","year":"2014","unstructured":"Schoofs T, Berdel W, M\u00fcller-Tidow C (2014) Origins of aberrant DNA methylation in acute myeloid leukemia. Leukemia 28(1):1\u201314","journal-title":"Leukemia"},{"issue":"3","key":"9841_CR114","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1365-2141.2004.05049.x","volume":"126","author":"E Serins\u00f6z","year":"2004","unstructured":"Serins\u00f6z E, Neusch M, B\u00fcsche G, Wasielewski R, Kreipe H, Bock O (2004) Aberrant expression of \u03b2-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia. Br J Haematol 126(3):313\u2013319","journal-title":"Br J Haematol"},{"issue":"11","key":"9841_CR115","doi-asserted-by":"publisher","first-page":"10627","DOI":"10.1007\/s13277-014-2610-9","volume":"35","author":"S Shahrabi","year":"2014","unstructured":"Shahrabi S, Azizidoost S, Shahjahani M, Rahim F, Ahmadzadeh A, Saki N (2014) New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia. Tumor Biol 35(11):10627\u201310633","journal-title":"Tumor Biol"},{"issue":"20","key":"9841_CR116","doi-asserted-by":"publisher","first-page":"6254","DOI":"10.1158\/1078-0432.CCR-17-0235","volume":"23","author":"N Shen","year":"2017","unstructured":"Shen N, Yan F, Pang J, Zhao N, Gangat N, Wu L, Bode AM, Al-Kali A, Litzow MR, Liu S (2017) Inactivation of receptor tyrosine kinases reverts aberrant DNA methylation in acute myeloid leukemia. Clin Cancer Res 23(20):6254\u20136266","journal-title":"Clin Cancer Res"},{"issue":"1","key":"9841_CR117","first-page":"179","volume":"30","author":"J-J Song","year":"2012","unstructured":"Song J-J, Liu Q, Li Y, Yang Z-S, Yang L, Xiang T-X, Ren G-S, Chen J-B (2012) Epigenetic inactivation of PLCD1 in chronic myeloid leukemia. Int J Mol Med 30(1):179\u2013184","journal-title":"Int J Mol Med"},{"issue":"17","key":"9841_CR118","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1093\/emboj\/17.17.5001","volume":"17","author":"FJ Stott","year":"1998","unstructured":"Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH (1998) The alternative product from the human CDKN2A locus, p14 ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J 17(17):5001\u20135014","journal-title":"EMBO J"},{"issue":"17","key":"9841_CR119","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1158\/1078-0432.CCR-07-0919","volume":"13","author":"G Strathdee","year":"2007","unstructured":"Strathdee G, Holyoake TL, Sim A, Parker A, Oscier DG, Melo JV, Meyer S, Eden T, Dickinson AM, Mountford JC (2007) Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin Cancer Res 13(17):5048\u20135055","journal-title":"Clin Cancer Res"},{"issue":"18","key":"9841_CR120","first-page":"6931","volume":"61","author":"B Sun","year":"2001","unstructured":"Sun B, Jiang G, Zaydan M-AA, La Russa VF, Safah H, Ehrlich M (2001) ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors. Can Res 61(18):6931\u20136937","journal-title":"Can Res"},{"issue":"4","key":"9841_CR121","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1084\/jem.20060750","volume":"204","author":"Y Tadokoro","year":"2007","unstructured":"Tadokoro Y, Ema H, Okano M, Li E, Nakauchi H (2007) De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells. J Exp Med 204(4):715\u2013722","journal-title":"J Exp Med"},{"issue":"6934","key":"9841_CR122","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nature01570","volume":"422","author":"K-I Takemaru","year":"2003","unstructured":"Takemaru K-I, Yamaguchi S, Lee YS, Zhang Y, Carthew RW, Moon RT (2003) Chibby, a nuclear \u03b2-catenin-associated antagonist of the Wnt\/Wingless pathway. Nature 422(6934):905\u2013909","journal-title":"Nature"},{"issue":"7","key":"9841_CR123","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/cdd.2010.6","volume":"17","author":"M Takeuchi","year":"2010","unstructured":"Takeuchi M, Kimura S, Kuroda J, Ashihara E, Kawatani M, Osada H, Umezawa K, Yasui E, Imoto M, Tsuruo T (2010) Glyoxalase-I is a novel target against Bcr-Abl\u00a0+\u00a0leukemic cells acquiring stem-like characteristics in a hypoxic environment. Cell Death Differ 17(7):1211\u20131220","journal-title":"Cell Death Differ"},{"key":"9841_CR124","doi-asserted-by":"crossref","unstructured":"Thanendrarajan S, Kim Y, Schmidt-Wolf I (2011) Understanding and targeting the Wnt\/\u03b2-catenin signaling pathway in chronic leukemia. Leuk Res Treat 2011","DOI":"10.4061\/2011\/329572"},{"issue":"10","key":"9841_CR125","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s11605-008-0573-0","volume":"12","author":"M Thangaraju","year":"2008","unstructured":"Thangaraju M, Cresci G, Itagaki S, Mellinger J, Browning DD, Berger FG, Prasad PD, Ganapathy V (2008) Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer. J Gastrointest Surg 12(10):1773\u20131782","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"9841_CR126","doi-asserted-by":"publisher","first-page":"e559","DOI":"10.1038\/bcj.2017.36","volume":"7","author":"E Togasaki","year":"2017","unstructured":"Togasaki E, Takeda J, Yoshida K, Shiozawa Y, Takeuchi M, Oshima M, Saraya A, Iwama A, Yokote K, Sakaida E (2017) Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia. Blood Cancer J 7(4):e559","journal-title":"Blood Cancer J"},{"issue":"11","key":"9841_CR127","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nrm2039","volume":"7","author":"NK Tonks","year":"2006","unstructured":"Tonks NK (2006) Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 7(11):833\u2013846","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"9841_CR128","first-page":"1061","volume":"20","author":"N Tsukamoto","year":"1992","unstructured":"Tsukamoto N, Morita K, Karasawa M, Omine M (1992) Methylation status of c-myc oncogene in leukemic cells: hypomethylation in acute leukemia derived from myelodysplastic syndromes. Exp Hematol 20(9):1061\u20131064","journal-title":"Exp Hematol"},{"issue":"1","key":"9841_CR129","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3892\/ol.2011.419","volume":"3","author":"E Uehara","year":"2012","unstructured":"Uehara E, Takeuchi S, Yang Y, Fukumoto T, Matsuhashi Y, Tamura T, Matsushita M, Nagai M, Koeffler HP, Tasaka T (2012) Aberrant methylation in promoter-associated CpG islands of multiple genes in chronic myelogenous leukemia blast crisis. Oncology letters 3(1):190\u2013192","journal-title":"Oncology letters"},{"issue":"1","key":"9841_CR130","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0304-3835(98)00344-9","volume":"137","author":"CC Niekerk van","year":"1999","unstructured":"van Niekerk CC, Poels LG (1999) Reduced expression of protein tyrosine phosphatase gamma in lung and ovarian tumors. Cancer Lett 137(1):61\u201373","journal-title":"Cancer Lett"},{"issue":"20","key":"9841_CR131","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1242\/jcs.114.20.3591","volume":"114","author":"AR Venkitaraman","year":"2001","unstructured":"Venkitaraman AR (2001) Functions of BRCA1 and BRCA2 in the biological response to DNA damage. J Cell Sci 114(20):3591\u20133598","journal-title":"J Cell Sci"},{"issue":"5","key":"9841_CR132","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2559.2007.02661.x","volume":"50","author":"M Vezzalini","year":"2007","unstructured":"Vezzalini M, Mombello A, Menestrina F, Mafficini A, Della Peruta M, Van Niekerk C, Barbareschi M, Scarpa A, Sorio C (2007) Expression of transmembrane protein tyrosine phosphatase gamma (PTP\u03b3) in normal and neoplastic human tissues. Histopathology 50(5):615\u2013628","journal-title":"Histopathology"},{"issue":"1","key":"9841_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(00)00092-5","volume":"247","author":"A Vidal","year":"2000","unstructured":"Vidal A, Koff A (2000) Cell-cycle inhibitors: three families united by a common cause. Gene 247(1):1\u201315","journal-title":"Gene"},{"issue":"1","key":"9841_CR135","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1756-9966-29-54","volume":"29","author":"Y-L Wang","year":"2010","unstructured":"Wang Y-L, Qian J, Lin J, Yao D-M, Qian Z, Zhu Z-H, Li J-Y (2010) Methylation status of DDIT3 gene in chronic myeloid leukemia. J Exp Clin Cancer Res 29(1):54","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"9841_CR136","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1182\/blood-2008-01-128595","volume":"112","author":"SP Whitman","year":"2008","unstructured":"Whitman SP, Hackanson B, Liyanarachchi S, Liu S, Rush LJ, Maharry K, Margeson D, Davuluri R, Wen J, Witte T (2008) DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication. Blood 112(5):2013\u20132016","journal-title":"Blood"},{"issue":"22","key":"9841_CR137","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.313104","volume":"18","author":"A Wilson","year":"2004","unstructured":"Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM, Pasche A-C, Knabenhans C, MacDonald HR, Trumpp A (2004) c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 18(22):2747\u20132763","journal-title":"Genes Dev"},{"issue":"5","key":"9841_CR138","doi-asserted-by":"publisher","first-page":"520","DOI":"10.4161\/cbt.10.5.12726","volume":"10","author":"T Xiang","year":"2010","unstructured":"Xiang T, Li L, Fan Y, Jiang Y, Ying Y, Putti TC, Tao Q, Ren G (2010) PLCD1 is a functional tumor suppressor inducing G2\/M arrest and frequently methylated in breast cancer. Cancer Biol Ther 10(5):520\u2013527","journal-title":"Cancer Biol Ther"},{"key":"9841_CR139","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.2741\/3051","volume":"13","author":"D Xu","year":"2008","unstructured":"Xu D, Qu C-K (2008) Protein tyrosine phosphatases in the JAK\/STAT pathway. Front Biosci 13:4925","journal-title":"Front Biosci"},{"issue":"12","key":"9841_CR140","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/j.1349-7006.2006.00331.x","volume":"97","author":"MY Yang","year":"2006","unstructured":"Yang MY, Chang JG, Lin PM, Tang KP, Chen YH, Lin HYH, Liu TC, Hsiao HH, Liu YC, Lin SF (2006) Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3. Cancer Sci 97(12):1298\u20131307","journal-title":"Cancer Sci"},{"issue":"1","key":"9841_CR141","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12185-012-1106-x","volume":"96","author":"H Yang","year":"2012","unstructured":"Yang H, Liang H, Yan J-S, Tao R, Hao S-G, Ma L-Y (2012) Down-regulation of hematopoiesis master regulator PU. 1 via aberrant methylation in chronic myeloid leukemia. Int J Hematol 96(1):65\u201373","journal-title":"Int J Hematol"},{"issue":"6","key":"9841_CR142","first-page":"6450","volume":"8","author":"D-M Yao","year":"2015","unstructured":"Yao D-M, Zhou J-D, Zhang Y-Y, Yang L, Wen X-M, Yang J, Guo H, Chen Q, Lin J, Qian J (2015) GPX3 promoter is methylated in chronic myeloid leukemia. Int J Clin Exp Pathol 8(6):6450","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"9841_CR143","first-page":"29","volume":"28","author":"H Yoshikawa","year":"2001","unstructured":"Yoshikawa H, Matsubara K, Qian G-S, Jackson P, Groopman JD, Manning JE, Harris CC, Herman JG (2001) SOCS-1, a negative regulator of the JAK\/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 28(1):29\u201335","journal-title":"Nat Genet"},{"issue":"4","key":"9841_CR144","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0002-9440(10)64629-9","volume":"157","author":"Q Zhang","year":"2000","unstructured":"Zhang Q, Raghunath PN, Vonderheid E, \u00d8dum N, Wasik MA (2000) Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter. Am J Pathol 157(4):1137\u20131146","journal-title":"Am J Pathol"},{"key":"9841_CR145","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/bjh.14739","volume":"178","author":"X Zhang","year":"2017","unstructured":"Zhang X, Yang L, Liu X, Nie Z, Wang X, Pan Y, Luo J (2017) Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia. Br J Haematol 178:728\u2013738","journal-title":"Br J Haematol"},{"issue":"12","key":"9841_CR146","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.18632\/oncotarget.1446","volume":"4","author":"J Zhong","year":"2013","unstructured":"Zhong J, Shaik S, Wan L, Tron AE, Wang Z, Sun L, Inuzuka H, Wei W (2013) SCF\u03b2-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration. Oncotarget 4(12):2339","journal-title":"Oncotarget"},{"issue":"4","key":"9841_CR147","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.bbrc.2015.06.095","volume":"463","author":"J-D Zhou","year":"2015","unstructured":"Zhou J-D, Wang Y-X, Zhang T-J, Yang D-Q, Yao D-M, Guo H, Yang L, Ma J-C, Wen X-M, Yang J (2015) Epigenetic inactivation of DLX4 is associated with disease progression in chronic myeloid leukemia. Biochem Biophys Res Commun 463(4):1250\u20131256","journal-title":"Biochem Biophys Res Commun"},{"key":"9841_CR148","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1002\/jcp.26119","volume":"233","author":"JD Zhou","year":"2017","unstructured":"Zhou JD, Lin J, Zhang TJ, Ma JC, Li XX, Wen XM, Guo H, Xu ZJ, Deng ZQ, Zhang W (2017) Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia. Journal of Cellular Physiology 233:2444\u20132450","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"9841_CR149","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/138161210789941883","volume":"16","author":"J Zivny","year":"2010","unstructured":"Zivny J, Klener P Jr, Pytlik R, Andera L (2010) The role of apoptosis in cancer development and treatment: focusing on the development and treatment of hematologic malignancies. Curr Pharm Des 16(1):11\u201333","journal-title":"Curr Pharm Des"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10528-018-9841-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-018-9841-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-018-9841-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T20:53:13Z","timestamp":1719780793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10528-018-9841-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,31]]},"references-count":146,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["9841"],"URL":"https:\/\/doi.org\/10.1007\/s10528-018-9841-1","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,31]]},"assertion":[{"value":"10 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}